Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuichiro Nagai
Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients
Cancer Research
Cancer Research
Oncology
Related publications
EZH2 Overexpression Is Associated With Poor Prognosis in Patients With Glioma
Oncotarget
Oncology
Elevated Serum Level of Angiopoietin-2 as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Serpin Peptidase Inhibitor, Clade a Member 3 (SERPINA3), Is Overexpressed in Glioma and Associated With Poor Prognosis in Glioma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy
Respiratory Research
Pulmonary
Respiratory Medicine
KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis
Tumor Biology
Medicine
Cancer Research
Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis
British Journal of Cancer
Cancer Research
Oncology
Serum D-Dimer Is a Potential Predictor for Thromboembolism Complications in Patients With Renal Biopsy
Scientific Reports
Multidisciplinary
Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Increased Expression of Pituitary Tumor-Transforming Gene (PTTG)-1 Is Correlated With Poor Prognosis in Glioma Patients
Oncology Reports
Medicine
Cancer Research
Oncology
